Travaux scientifiques

Prof. Dr. Ersin Özaslan

53 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil
  1. Tumor Volume Is a Better Prognostic Factor than Greatest Tumor Diameter in Operated Stage I-III Non–Small-Cell Lung Cancer

    Clinical Lung Cancer, 2023

    DOI 10.1016/j.cllc.2023.02.009 PMID 37019814 4 citations (Europe PMC) Source : OpenAlex

  2. Is SUVmax of 18F-FDG PET/CT Predictive Factor for Malignancy in Gastrointestinal Tract?

    Nigerian Journal of Clinical Practice, 2021

    DOI 10.4103/njcp.njcp_637_18 PMID 34397034 4 citations (Europe PMC) Source : OpenAlex

  3. A single-center observational study assessing the predictive factors associated with the prognosis of acromegaly

    Growth Hormone & IGF Research, 2020

    DOI 10.1016/j.ghir.2020.101342 PMID 32916586 6 citations (Europe PMC) Source : OpenAlex

  4. Comorbidity and polypharmacy in patients with breast cancer

    Breast Cancer, 2020

    DOI 10.1007/s12282-019-01040-8 PMID 31898155 19 citations (Europe PMC) Source : OpenAlex

  5. Chemotherapy at the End of Life

    Journal of Palliative Care, 2020

    DOI 10.1177/0825859720946505 PMID 32762320 11 citations (Europe PMC) Source : OpenAlex

  6. The role of primary tumor resection in patients with stage IV colorectal cancer with unresectable metastases.

    PubMed, 2020

    PMID 32521889 7 citations (Europe PMC) Source : OpenAlex

  7. Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.

    PubMed, 2019

    PMID 31786850 1 citation (Europe PMC) Source : OpenAlex

  8. Breast carcinoma detected in breast specimens: A fifteen-year single-center experience

    Annals of Medical Research, 2019

    DOI 10.5455/annalsmedres.2019.05.287 Source : OpenAlex

  9. Effectiveness and Safety of LMWH Treatment in Patients With Cancer Diagnosed With Non-High-Risk Venous Thromboembolism: Turkish Observational Study (TREBECA)

    Clinical and Applied Thrombosis/Hemostasis, 2018

    DOI 10.1177/1076029617753538 PMID 29455568 4 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  10. Efficacy and safety of cetuximab plus FOLFOX in second-line and third-line therapy in metastatic colorectal cancer.

    PubMed, 2017

    PMID 29155512 4 citations (Europe PMC) Source : OpenAlex

  11. Rechallenge chemotherapy as a third line treatment option for metastatic colorectal carcinoma

    Ortadoğu Tıp Dergisi, 2017

    DOI 10.21601/ortadogutipdergisi.296006 Source : OpenAlex

  12. THE RELATIONSHIP BETWEEN NEUTROPHİL / LYMPHOCYTES RATIO AND PLATELET / LYMPHOCYTES RATIO WITH PROGNOSIS IN OPERATED STAGE 1-2 OF NON- SMALL CELL LUNG CANCER DISEASE: ONE CENTRAL EXPERIENCE

    Anadolu Kliniği Tıp Bilimleri Dergisi, 2017

    DOI 10.21673/anadoluklin.315155 Source : OpenAlex

  13. The assessment of bone marrow infiltration with 18FDG-PET in non-haematopoietic solid tumors

    Acta Oncologica Turcica, 2017

    DOI 10.5505/aot.2017.92486 Source : OpenAlex

  14. Effectiveness and safety of LMWH treatment in patients with cancer diagnosed with nonhigh-risk venous thromboembolism (VTE): Results of the Turkish observational study (TREBECA).

    Journal of Clinical Oncology, 2017

    DOI 10.1200/jco.2017.35.15_suppl.e21656 Source : OpenAlex

  15. Effect of tumor location in metastatic colorectal cancer to response anti-EGFR and anti-VEGF treatment: One center study.

    Journal of Clinical Oncology, 2017

    DOI 10.1200/jco.2017.35.15_suppl.e15023 Source : OpenAlex

  16. Evre 1–2 Opere Küçük Hücreli Dışı Akciğer Kanseri Hastalarında Nötrofil/Lenfosit ve Platelet/Lenfosit Oranlarının Prognoz ile İlişkisi: Tek Merkez Deneyimi

    2017

    Source : OpenAlex

  17. EFFECTIVENESS AND SAFETY OF LMWH TREATMENT IN CANCER PATIENTS DIAGNOSED WITH NON-HIGH RISK VENOUS THROMBOEMBOLISM (VTE) - RESULTS OF TURKISH OBSERVATIONAL STUDY (TREBECA)

    Bursa Uludag University - AVESIS, 2017

    Source : OpenAlex

  18. Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in gastroenteropancreatic neuroendocrine tumors

    European Journal of Gastroenterology & Hepatology, 2016

    DOI 10.1097/meg.0000000000000619 PMID 26945127 12 citations (Europe PMC) Source : OpenAlex

  19. Best prognostic factor of neuroendocrine tumors: Grade or Stage? A multidisciplinary single-center study

    The Turkish Journal of Gastroenterology, 2016

    DOI 10.5152/tjg.2016.16391 PMID 27852541 8 citations (Europe PMC) Source : OpenAlex

  20. Comparison of survival with somatostatin analog and chemotherapy and prognostic factors for treatment in 165 advanced neuroendocrine tumor patients with Ki-67 20% or less

    Anti-Cancer Drugs, 2016

    DOI 10.1097/cad.0000000000000445 PMID 27768606 7 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  21. Nöroendokrin Tümörlerde Endokrin ve Metabolik Aciller

    Turkiye Klinikleri Endocrinology - Special Topics, 2016

    Source : OpenAlex

  22. Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in GEP-NETs.

    Journal of Clinical Oncology, 2016

    DOI 10.1200/jco.2016.34.15_suppl.e15646 Source : OpenAlex

  23. Pulmonary Extramedullary Hematopoiesis Mimicking Plasmacytoma in a Patient with Multiple Myeloma

    Romanian Journal of Internal Medicine, 2015

    DOI 10.1515/rjim-2015-0046 PMID 26939213 5 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  24. Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology

    Tumor Biology, 2015

    DOI 10.1007/s13277-015-4359-1 PMID 26553363 13 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  25. Is positive staining of nonfunctioning pituitary adenomas for luteinizing hormone associated with poor prognosis?

    Turkish Neurosurgery, 2015

    DOI 10.5137/1019-5149.jtn.14889-15.1 PMID 27593756 Texte intégral en libre accèsSource : OpenAlex

  26. Salvage Chemotherapy with Weekly Paclitaxel for Metastatic Melanoma

    Asian Pacific Journal of Cancer Prevention, 2015

    DOI 10.7314/apjcp.2015.16.6.2581 PMID 25824800 Texte intégral en libre accèsSource : OpenAlex

  27. Predicting the role of the pretreatment neutrophil to lymphocyte ratio in the survival of early triple-negative breast cancer patients.

    PubMed, 2015

    PMID 26854438 22 citations (Europe PMC) Source : OpenAlex

  28. Factors Affecting Prognosis in Metastatic Colorectal Cancer Patients

    Asian Pacific Journal of Cancer Prevention, 2015

    DOI 10.7314/apjcp.2015.16.7.3015 PMID 25854399 17 citations (Europe PMC) Source : OpenAlex

  29. Is sunitinib-induced hypothyroidism a predictive clinical marker for better response in metastatic renal cell carcinoma patients?

    Journal of Chemotherapy, 2015

    DOI 10.1179/1973947815y.0000000039 PMID 25948423 11 citations (Europe PMC) Source : OpenAlex

  30. Psychological distress and loneliness in caregiver of advanced oncological inpatients

    Journal of Health Psychology, 2015

    DOI 10.1177/1359105314567770 PMID 25631663 21 citations (Europe PMC) Source : OpenAlex

  31. Predictive Significance of VEGF and HIF-1α Expression in Patients with Metastatic Colorectal Cancer Receiving Chemotherapy Combinations with Bevacizumab

    Asian Pacific Journal of Cancer Prevention, 2015

    DOI 10.7314/apjcp.2015.16.14.6149 PMID 26320510 15 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  32. Analyses of Multiple Factors for Determination of "Selected Patients" Who Should Receive Rechallenge Treatment in Metastatic Colorectal Cancer: a Retrospective Study from Turkey

    Asian Pacific Journal of Cancer Prevention, 2015

    DOI 10.7314/apjcp.2015.16.7.2833 PMID 25854370 6 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  33. Primary Pleomorphic Rhabdomyosarcoma of Thyroid Gland in an Adult Patient: A Case Report

    Eurasian Journal of Medicine, 2015

    DOI 10.5152/eurasianjmed.2015.96 PMID 27026769 8 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  34. Is Late Recurrence a Predictive Clinical Marker for Better Sunitinib Response in Metastatic Renal Cell Carcinoma Patients?

    Clinical Genitourinary Cancer, 2015

    DOI 10.1016/j.clgc.2015.07.005 PMID 26320661 5 citations (Europe PMC) Source : OpenAlex

  35. Drug Induced Lupus Erythematosus Due to Capecitabine and Bevacizumab Treatment Presenting with Prolonged Thrombocytopenia

    Romanian Journal of Internal Medicine, 2015

    DOI 10.1515/rjim-2015-0037 PMID 26710505 3 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  36. Bilateral Adrenal Incidentalomas: A Rare Presentation of Lung Cancer

    Case Reports in Endocrinology, 2015

    DOI 10.1155/2015/179472 PMID 26101674 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  37. Are Rogerofenib and Nilotinib Effective for Advanced Gastrointestinal Stromal Tumor (GIST) Patients who have Already been Given Main Treatments?

    Asian Pacific Journal of Cancer Prevention, 2015

    DOI 10.7314/apjcp.2015.16.11.4801 PMID 26107244 1 citation (Europe PMC) Source : OpenAlex

  38. Is sunitinib-induced hypothyroidism a predictive clinical marker for better response in metastatic renal cell carcinoma patients?

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e15624 Source : OpenAlex

  39. 1619 Low molecular weight heparin (LMWH) treatment in cancer patients with low risk venous thromboembolism - results of Turkish Observational Study (TREBECA)

    European Journal of Cancer, 2015

    DOI 10.1016/s0959-8049(16)30707-9 Source : OpenAlex

  40. Prognostic factors obtained from long-term follow-up of pituitary adenomas and other sellar tumors

    Turkish Neurosurgery, 2014

    DOI 10.5137/1019-5149.jtn.9140-13.1 PMID 25269036 6 citations (Europe PMC) Source : OpenAlex

  41. Albumin-globulin Ratio for Prediction of Long-term Mortality in Lung Adenocarcinoma Patients

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.15.6449 PMID 25124641 49 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  42. Clinicopathological Characteristics and Prognosis of Patients According to Recurrence Time After Curative Resection for Colorectal Cancer

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.21.9277 PMID 25422212 17 citations (Europe PMC) Source : OpenAlex

  43. Positive Effects of Oral β-Glucan on Mucositis and Leukopenia in Colorectal Cancer Patients Receiving Adjuvant FOLFOX-4 Combination Chemotherapy

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.8.3641 PMID 24870771 15 citations (Europe PMC) Source : OpenAlex

  44. Haematologic Parameters in Metastatic Colorectal Cancer Patients Treated with Capecitabine Combination Therapy

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.1.253 PMID 24528035 12 citations (Europe PMC) Source : OpenAlex

  45. Lack of Prognostic Value of Mean Corpuscular Volume with Capecitabine Therapy in Metastatic Breast Cancer

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.6.2501 PMID 24761854 3 citations (Europe PMC) Source : OpenAlex

  46. An Overview of Neuroendocrine Tumour Markers

    Endocrinology research and practice., 2014

    DOI 10.4274/tjem.2422 Source : OpenAlex

  47. Efficacy and safety of raltitrexed combinations with uracil-tegafur or Mitomycin C as salvage treatment in advanced colorectal cancer patients.

    Journal of Clinical Oncology, 2014

    DOI 10.1200/jco.2014.32.3_suppl.662 Source : OpenAlex

  48. Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer

    Medical Oncology, 2013

    DOI 10.1007/s12032-013-0801-7 PMID 24326984 49 citations (Europe PMC) Source : OpenAlex

  49. The Retroconversion of Immature Teratoma with Chemotherapy: A Case Report and Review of the Literature

    Erciyes Medical Journal, 2013

    DOI 10.5152/etd.2013.66 Source : OpenAlex

  50. Primary hepatic carcinosarcoma

    Hepatobiliary & pancreatic diseases international, 2011

    DOI 10.1016/s1499-3872(11)60015-5 PMID 21269943 14 citations (Europe PMC) Source : OpenAlex